Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

PRECLINICAL STUDIES TO ASSESS ACUTE AND CHRONIC TOXICITIES OF A CANDIDATE DRUG BASED ON COMPLEMENT C3 NEODETERMINANT RECOMBINANT HUMANIZED ANTIBODY FOR TREATMENT OF TRAUMATIC BRAIN INJURIES

A.V. Trofimov,A.V. Zhakhov,S.V. Rodin,N.P. Gorbunov, A.V. Petrov,N.V. Pigareva,G.V. Aleksandrov,M.S. Zakharov,А.S. Kiryanova,О.E. Khuttunen,I.V. Bendt,A.E. Krylova,A.M. Ischenko

http://eng.biomos.ru/conference/articles.htmBIOTECHNOLOGY: STATE OF THE ART AND PERSPECTIVES（2021）

Cited 0|Views2
No score
Abstract
A drug based on complement C3 neodeterminant recombinant humanized antibody for the treatment of traumatic brain injuries belongs to the class III of low-risk drugs.
More
Translated text
Key words
recombinant humanized antibody
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined